These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15209536)

  • 41. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].
    Kavardzhikova S; Pechlivanov B
    Akush Ginekol (Sofiia); 2010; 49(4):32-7. PubMed ID: 20734639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic profile in sons of women with polycystic ovary syndrome.
    Recabarren SE; Smith R; Rios R; Maliqueo M; Echiburú B; Codner E; Cassorla F; Rojas P; Sir-Petermann T
    J Clin Endocrinol Metab; 2008 May; 93(5):1820-6. PubMed ID: 18230657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does a male polycystic ovarian syndrome equivalent exist?
    Cannarella R; Condorelli RA; Mongioì LM; La Vignera S; Calogero AE
    J Endocrinol Invest; 2018 Jan; 41(1):49-57. PubMed ID: 28711970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y; Gao X; Sun X; Zhang P; Chen Z
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
    Apridonidze T; Essah PA; Iuorno MJ; Nestler JE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1929-35. PubMed ID: 15623819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.
    Livadas S; Chaskou S; Kandaraki AA; Skourletos G; Economou F; Christou M; Boutzios G; Karachalios A; Zerva A; Xyrafis X; Christakou C; Pighou AK; Diamanti-Kandarakis E
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):698-703. PubMed ID: 21605157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.
    Vural B; Caliskan E; Turkoz E; Kilic T; Demirci A
    Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
    Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome.
    Stárka L; Dušková M
    Prague Med Rep; 2021; 122(2):73-79. PubMed ID: 34137683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.
    Shorakae S; Boyle J; Teede H
    Intern Med J; 2014 Aug; 44(8):720-6. PubMed ID: 24909750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between INS-VNTR polymorphism and polycystic ovary syndrome in a Korean population.
    Yun JH; Gu BH; Kang YB; Choi BC; Song S; Baek KH
    Gynecol Endocrinol; 2012 Jul; 28(7):525-8. PubMed ID: 22468791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.